Evidence map›Paper›PMID 36054185›Full record

ArticlePloS one2022

Changes in the proteome and secretome of rat liver sinusoidal endothelial cells during early primary culture and effects of dexamethasone.

Ruomei Li, Sabin Bhandari, Inigo Martinez-Zubiaurre, Jack-Ansgar Bruun, Ilona Urbarova, Bård Smedsrød, Jaione Simón-Santamaría, Karen Kristine Sørensen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ruomei LiDepartment of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.
Sabin BhandariDepartment of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0003-3837-027X
Inigo Martinez-ZubiaurreDepartment of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.
Jack-Ansgar BruunDepartment of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.
Ilona UrbarovaDepartment of Community Medicine, UiT-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0001-6626-2917
Bård SmedsrødDepartment of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.
Jaione Simón-SantamaríaDepartment of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-0688-2150
Karen Kristine SørensenDepartment of Medical Biology, UiT-The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0002-7570-186X
UiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLiver sinusoidal endothelial cells (LSECs) are specialized fenestrated scavenger endothelial cells involved in the elimination of modified plasma proteins and tissue turnover waste macromolecules from blood. LSECs also participate in liver immune responses. A challenge when studying LSEC biology is the rapid loss of the in vivo phenotype in culture. In this study, we have examined biological processes and pathways affected during early-stage primary culture of rat LSECs and checked for cell responses to the pro-inflammatory cytokine interleukin (IL)-1β and the anti-inflammatory drug dexamethasone.

methodsLSECs from male Sprague Dawley rats were cultured on type I collagen in 5% oxygen atmosphere in DMEM with serum-free supplements for 2 and 24 h. Quantitative proteomics using tandem mass tag technology was used to examine proteins in cells and supernatants. Validation was done with qPCR, ELISA, multiplex immunoassay, and caspase 3/7 assay. Cell ultrastructure was examined by scanning electron microscopy, and scavenger function by quantitative endocytosis assays.

resultsLSECs cultured for 24 h showed a characteristic pro-inflammatory phenotype both in the presence and absence of IL-1β, with upregulation of cellular responses to cytokines and interferon-γ, cell-cell adhesion, and glycolysis, increased expression of fatty acid binding proteins (FABP4, FABP5), and downregulation of several membrane receptors (STAB1, STAB2, LYVE1, CLEC4G) and proteins in pyruvate metabolism, citric acid cycle, fatty acid elongation, amino acid metabolism, and oxidation-reduction processes. Dexamethasone inhibited apoptosis and improved LSEC viability in culture, repressed inflammatory and immune regulatory pathways and secretion of IL-1β and IL-6, and further upregulated FABP4 and FABP5 compared to time-matched controls. The LSEC porosity and endocytic activity were reduced at 24 h both with and without dexamethasone but the dexamethasone-treated cells showed a less stressed phenotype.

conclusionRat LSECs become activated towards a pro-inflammatory phenotype during early culture. Dexamethasone represses LSEC activation, inhibits apoptosis, and improves cell viability.

Indexed as

Endothelial CellsProteomeAnimalsDexamethasoneLiverMaleRatsRats, Sprague-DawleySecretomeDexamethasoneProteome

Identifiers

PMID36054185
PMCPMC9439253
OpenAlexW4294295665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.